Top headlines: RIL shareholders approve Saudi appointment; setback for Zee

Business Standard brings you the top stories from today

Saudi Aramco Chairman Yasir Al-Rumayyan
Saudi Aramco Chairman Yasir Al-Rumayyan
BS Web Team New Delhi
2 min read Last Updated : Oct 21 2021 | 8:40 PM IST
RIL shareholders pass resolution to add Saudi Aramco chairman as director

Reliance Industries Ltd said on Thursday that a required majority of its shareholders have passed the resolution to appoint Saudi Aramco Chairman Yasir Al-Rumayyan as an independent director to the conglomerate's board.

A little over 98% of the total votes polled on the resolution were in favour of Al-Rumayyan's addition, Reliance said in a statement. The announcement comes a day ahead of RIL's Q2 results. Read more

Bombay HC asks Zee to call the EGM as requisitioned by Invesco

In a setback for Zee Entertainment Enterprises, Bombay High Court on Thursday asked the company to call an EGM as requisitioned Zee's largest shareholder Invesco. The bench suggested a neutral chairperson, including anyone from the corporate world, lawyer or retired judge should head the meeting.

Zee said it will inform the court of the EGM date by Friday morning. Read more

Centre approves 3% Dearness Allowance hike for central govt employees

Ahead of festive season, the Union Cabinet on Thursday approved a 3% hike in Dearness Allowance (DA) and Dearness Relief (DR) for the central government employees and pensioners with effect from July 1, 2021, said Union Minister Anurag Thakur. Prior to this, in July the government had decided to hike the DA for central government employees by 11%, from 17% to 28%. After this hike, the DA will increase to 31%. Read more

Pfizer says its booster shot is 95.6% effective against symptomatic Covid

Pfizer Inc. and BioNTech SE said a booster shot of their Covid-19 vaccine restored full protection in a large study, results that are likely to bolster the argument for giving a third dose more widely.

A booster was 95.6% effective against symptomatic Covid in the study, which followed 10,000 people aged 16 and older, the companies said on Thursday. Read more

Topics :SEBITop Business HeadlinesTop business storiesReliance IndustriesSaudi AramcoZee EntertainmentInvesco PfizerDearness AllowanceCoronavirus Vaccine

Next Story